
Overview
My goal is to provide the best care possible for patients with blood cancers and their families. I strive to find the best treatment for each patient based on the latest research as well as each patient's own unique situation and goals. I also hope to improve the care of cancer patients through access to clinical trials and ongoing outcomes-based research. My research focuses on physical fitness and cancer patients, survivorship care, and financial toxicity.
Dr. Sitlinger is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Richter Syndrome, and Bone Marrow Aspiration.
Dr. Sitlinger is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. She is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 1 clinical trial. Dr. Sitlinger is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Sitlinger has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Cancer Center
Diane Reidy-Lagunes is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy-Lagunes is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization. Dr. Reidy-Lagunes is currently accepting new patients.
Duke Cancer Center Sarcoma Clinic
I am a medical oncologist specializing in bone and soft tissue cancers called sarcomas. Sarcomas occur throughout the body, so I collaborate closely with colleagues from other specialties in a multidisciplinary team. I view my role in caring for someone's cancer as as privilege and strive to work together with each patient to ensure the best treatment decisions are made, all the while embracing each person's uniqueness as an individual. I see adult patients of all ages, but have a particular interest in the unique challenges facing a young adults with cancer. When I'm not working, you can find me exploring the outdoors with my family, traveling, and cooking. Dr. Grilley-Olson is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Rhabdomyosarcoma Embryonal. Dr. Grilley-Olson is board certified in American Board Of Internal Med, Medical Oncology. Dr. Grilley-Olson is currently accepting new patients.
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is highly rated in 23 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Crawford is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Hematology/Oncology , and American Board Of Internal Med, Medical Oncology. Dr. Crawford is currently accepting new patients.
Frequently Asked Questions about Dr. Andrea P. Sitlinger
How do I make an appointment with Dr. Andrea P. Sitlinger?
You can book an appointment with Dr. Andrea P. Sitlinger by calling their office at 919-684-8964. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Andrea P. Sitlinger a top-rated expert for Chronic B-Cell Leukemia (CBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrea P. Sitlinger is classified as an Elite expert for Chronic B-Cell Leukemia (CBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Andrea P. Sitlinger specialize in?
While Dr. Andrea P. Sitlinger is a Hematology Oncology, they have specific expertise in Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Small Lymphocytic Lymphoma (SLL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Andrea P. Sitlinger participate in research or clinical trials?
Yes. Dr. Andrea P. Sitlinger has published 30 articles and abstracts on conditions like Chronic B-Cell Leukemia (CBCL). You can view a list of Dr. Andrea P. Sitlinger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Andrea P. Sitlinger accept my insurance?
Dr. Andrea P. Sitlinger accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-684-8964 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic B-Cell Leukemia (CBCL)Dr. Sitlinger isElite. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Distinguished
- Richter SyndromeDr. Sitlinger isDistinguished. Learn about Richter Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Sitlinger isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- LeukemiaDr. Sitlinger isAdvanced. Learn about Leukemia.
- Experienced
- Anaplastic Large Cell LymphomaDr. Sitlinger isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Sitlinger isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Sitlinger isExperienced. Learn about Aplastic Anemia.
- Autoimmune Hemolytic AnemiaDr. Sitlinger isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Sitlinger isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Sitlinger isExperienced. Learn about Bone Marrow Aspiration.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Sitlinger isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Febrile NeutropeniaDr. Sitlinger isExperienced. Learn about Febrile Neutropenia.
- Follicular LymphomaDr. Sitlinger isExperienced. Learn about Follicular Lymphoma.
- Hairy Cell Leukemia (HCL)Dr. Sitlinger isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Large-Cell Immunoblastic LymphomaDr. Sitlinger isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Sitlinger isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Dr. Sitlinger isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Non-Hodgkin LymphomaDr. Sitlinger isExperienced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaDr. Sitlinger isExperienced. Learn about Peripheral T-Cell Lymphoma.
- Primary Lymphoma of the BrainDr. Sitlinger isExperienced. Learn about Primary Lymphoma of the Brain.
- Prolymphocytic LeukemiaDr. Sitlinger isExperienced. Learn about Prolymphocytic Leukemia.
- Pulmonary EmbolismDr. Sitlinger isExperienced. Learn about Pulmonary Embolism.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Sitlinger isExperienced. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- ReticuloendotheliosisDr. Sitlinger isExperienced. Learn about Reticuloendotheliosis.
- T-Cell LymphomaDr. Sitlinger isExperienced. Learn about T-Cell Lymphoma.
- Venous Thromboembolism (VTE)Dr. Sitlinger isExperienced. Learn about Venous Thromboembolism (VTE).
- Waldenstrom MacroglobulinemiaDr. Sitlinger isExperienced. Learn about Waldenstrom Macroglobulinemia.


